Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical study to examine the changes of purine compounds by the simultaneous administration of xanthine oxidase/xanthine dehydrogenase inhibitors and inosine in healthy subjects.

Trial Profile

Clinical study to examine the changes of purine compounds by the simultaneous administration of xanthine oxidase/xanthine dehydrogenase inhibitors and inosine in healthy subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Dec 2017

At a glance

  • Drugs Allopurinol (Primary) ; Febuxostat (Primary) ; Topiroxostat (Primary)
  • Indications Diabetic nephropathies; Gout; Hyperuricaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top